Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter AgfiledCriticalBaxter Ag
Publication of HUP0000824A1publicationCriticalpatent/HUP0000824A1/en
Publication of HUP0000824A3publicationCriticalpatent/HUP0000824A3/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Abstract
The invention relates to an immunotolerant prothrombin complex preparation, to a process for the production of this preparation and to the use of the preparation for producing a medicine.
SUBSTITUTED ESTRATRIENA 11β-HALOGEN-7 αTERSUBSTITUTATION, PROCESS FOR PRODUCING PHARMACEUTICAL PROPERTIES CONTAINING ESTRATRIENA 11β-HALOGEN-7 αINII AND ALSO USE FOR PHARMACEUTICAL PRODUCTION CONTAINING